You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

SPONTANEOUS CHOROIDAL HEMORRHAGE IN A PATIENT ON DABIGATRAN ETEXILATE (PRADAXA)

Kang, Terry S. MD*; Lord, Ken MD; Kunjukunju, Nancy MD*

RETINAL Cases & Brief Reports:
doi: 10.1097/ICB.0000000000000035
Case Report
Abstract

Purpose: To report the first known case of spontaneous choroidals in association with a patient on dabigatran etexilate.

Methods: Observational case report.

Results: An 82-year-old man on 150 mg dabigatran etexilate by mouth twice a day for atrial fibrillation developed spontaneous choroidal hemorrhage in his left eye. No other causes were found after careful history and examination.

Conclusion: Dabigatran is a popular new alternative to warfarin that has no blood monitoring or reversal agent. Physicians should be aware of this new medication and its possible hemorrhagic complications.

In Brief

Dabigatran is a popular new alternative to warfarin that has no blood monitoring or reversal agent. Physicians should be aware of this new medication and its possible hemorrhagic complications.

Author Information

*Department of Ophthalmology, University of Missouri–Kansas City, Kansas City, Missouri; and

Retina Associates of Southern Utah, St. George, Utah.

Reprint requests: Terry S. Kang, MD, Department of Ophthalmology, University of Missouri–Kansas City, 2300 Holmes Street, Kansas City, MO 64108; e-mail: terrykang@gmail.com

None of the authors have any financial/conflicting interests to disclose.

© 2014 by Ophthalmic Communications Society, Inc.